The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howland, K. C.
Right arrow Articles by Abbas, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howland, K. C.
Right arrow Articles by Abbas, A. K.
The Journal of Immunology, 2000, 164: 4465-4470.
Copyright © 2000 by The American Association of Immunologists

The Roles of CD28 and CD40 Ligand in T Cell Activation and Tolerance1

Kimberly C. Howland2, Lara J. Ausubel2, Cheryl A. London and Abul K. Abbas3

Immunology Research Division, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115

Costimulation of T cell activation involves both the B7:CD28 as well as the CD40 ligand (CD40L):CD40 pathway. To determine the importance of these pathways to in vitro and in vivo T cell activation, a direct comparison was made of the responses of TCR transgenic T cells lacking either CD28 or CD40L. In vitro, CD28-/- T cells showed a greater reduction in proliferative responses to Ag than did CD40L-/- T cells. The absence of CD28 resulted in defective Th2 responses, whereas CD40L-/- T cells were defective in Th1 development. In vivo, CD28-/- T cells failed to expand upon immunization, whereas CD40L-/- T cells could not sustain a response. These results suggest that CD28 is critical for initiating T cell responses, whereas CD40L is required for sustained Th1 responses. The different functional roles of these costimulatory pathways may explain why blocking B7:CD28 and CD40L:CD40 interactions has an additive effect in inhibiting T cell responses.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. J. Jenkins, G. Perona-Wright, and A. S. MacDonald
Full Development of Th2 Immunity Requires Both Innate and Adaptive Sources of CD154
J. Immunol., June 15, 2008; 180(12): 8083 - 8092.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. Daoussis, I. Antonopoulos, A. P. Andonopoulos, and S.-N. C. Liossis
Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis
Rheumatology, February 1, 2007; 46(2): 227 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Knoechel, J. Lohr, S. Zhu, L. Wong, D. Hu, L. Ausubel, and A. K. Abbas
Functional and Molecular Comparison of Anergic and Regulatory T Lymphocytes.
J. Immunol., June 1, 2006; 176(11): 6473 - 6483.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. MacLeod, M. J. Kwakkenbos, A. Crawford, S. Brown, B. Stockinger, K. Schepers, T. Schumacher, and D. Gray
CD4 memory T cells survive and proliferate but fail to differentiate in the absence of CD40
J. Exp. Med., April 17, 2006; 203(4): 897 - 906.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. E. Feldon, D. J. J. Park, C. W. O'Loughlin, V. T. Nguyen, S. Landskroner-Eiger, D. Chang, T. H. Thatcher, and R. P. Phipps
Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves' Ophthalmopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3913 - 3921.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. Pollard, M. Arnush, P. Hultman, and D. H. Kono
Costimulation Requirements of Induced Murine Systemic Autoimmune Disease
J. Immunol., November 1, 2004; 173(9): 5880 - 5887.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Lohr, B. Knoechel, E. C. Kahn, and A. K. Abbas
Role of B7 in T Cell Tolerance
J. Immunol., October 15, 2004; 173(8): 5028 - 5035.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Vasu, B. S. Prabhakar, and M. J. Holterman
Targeted CTLA-4 Engagement Induces CD4+CD25+CTLA-4high T Regulatory Cells with Target (Allo)antigen Specificity
J. Immunol., August 15, 2004; 173(4): 2866 - 2876.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Nagelkerken, I. Haspels, W. van Rijs, B. Blauw, J. L. Ferrant, D. M. Hess, E. A. Garber, F. R. Taylor, and L. C. Burkly
FcR Interactions Do Not Play a Major Role in Inhibition of Experimental Autoimmune Encephalomyelitis by Anti-CD154 Monoclonal Antibodies
J. Immunol., July 15, 2004; 173(2): 993 - 999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Xu, A. J. Lepisto, and R. L. Hendricks
CD154 Signaling Regulates the Th1 Response to Herpes Simplex Virus-1 and Inflammation in Infected Corneas
J. Immunol., July 15, 2004; 173(2): 1232 - 1239.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
D. Daoussis, A. P. Andonopoulos, and S.-N. C. Liossis
Targeting CD40L: a Promising Therapeutic Approach
Clin. Vaccine Immunol., July 1, 2004; 11(4): 635 - 641.
[Full Text]


Home page
J. Immunol.Home page
P. G. Andres, K. C. Howland, D. Dresnek, S. Edmondson, A. K. Abbas, and M. F. Krummel
CD28 Signals in the Immature Immunological Synapse
J. Immunol., May 15, 2004; 172(10): 5880 - 5886.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Attanavanich and J. F. Kearney
Marginal Zone, but Not Follicular B Cells, Are Potent Activators of Naive CD4 T Cells
J. Immunol., January 15, 2004; 172(2): 803 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. K. Deenick, A. V. Gett, and P. D. Hodgkin
Stochastic Model of T Cell Proliferation: A Calculus Revealing IL-2 Regulation of Precursor Frequencies, Cell Cycle Time, and Survival
J. Immunol., May 15, 2003; 170(10): 4963 - 4972.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Mueller and A. August
Attenuation of Immunological Symptoms of Allergic Asthma in Mice Lacking the Tyrosine Kinase ITK
J. Immunol., May 15, 2003; 170(10): 5056 - 5063.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. DAVIDSON, X. WANG, M. MIHARA, M. RAMANUJAM, W. HUANG, L. SCHIFFER, and J. SINHA
Co-Stimulatory Blockade in the Treatment of Murine Systemic Lupus Erythematosus (SLE)
Ann. N.Y. Acad. Sci., April 1, 2003; 987(1): 188 - 198.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
U. M. Padigel and J. P. Farrell
CD40-CD40 Ligand Costimulation Is Not Required for Initiation and Maintenance of a Th1-Type Response to Leishmania major Infection
Infect. Immun., March 1, 2003; 71(3): 1389 - 1395.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. J. Murphy, L. Welniak, T. Back, J. Hixon, J. Subleski, N. Seki, J. M. Wigginton, S. E. Wilson, B. R. Blazar, A. M. Malyguine, et al.
Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses
J. Immunol., March 1, 2003; 170(5): 2727 - 2733.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Holzer, W. W. Kwok, G. T. Nepom, and J. H. Buckner
Differential Antigen Sensitivity and Costimulatory Requirements in Human Th1 and Th2 Antigen-Specific CD4+ Cells with Similar TCR Avidity
J. Immunol., February 1, 2003; 170(3): 1218 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. S. Vacchio and R. J. Hodes
CD28 Costimulation Is Required for In Vivo Induction of Peripheral Tolerance in CD8 T Cells
J. Exp. Med., January 6, 2003; 197(1): 19 - 26.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. E. Christensen, J. P. Christensen, N. N. Kristensen, N. J. V. Hansen, A. Stryhn, and A. R. Thomsen
Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells
Int. Immunol., July 1, 2002; 14(7): 701 - 711.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. Rajagopalan, M. K. Smart, E. V. Marietta, and C. S. David
Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice
Int. Immunol., July 1, 2002; 14(7): 801 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Marzo, V. Vezys, K. Williams, D. F. Tough, and L. Lefrancois
Tissue-Level Regulation of Th1 and Th2 Primary and Memory CD4 T Cells in Response to Listeria Infection
J. Immunol., May 1, 2002; 168(9): 4504 - 4510.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Nierkens, P. van Helden, M. Bol, R. Bleumink, P. van Kooten, S. Ramdien-Murli, L. Boon, and R. Pieters
Selective Requirement for CD40-CD154 in Drug-Induced Type 1 Versus Type 2 Responses to Trinitrophenyl-Ovalbumin
J. Immunol., April 15, 2002; 168(8): 3747 - 3754.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Snyder, X. Zhang, and L. J. Wysocki
Negligible Class II MHC Presentation of B Cell Receptor-Derived Peptides by High Density Resting B Cells
J. Immunol., April 15, 2002; 168(8): 3865 - 3873.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. L. Compton and J. P. Farrell
CD28 Costimulation and Parasite Dose Combine to Influence the Susceptibility of BALB/c Mice to Infection with Leishmania major
J. Immunol., February 1, 2002; 168(3): 1302 - 1308.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zaffran, O. Destaing, A. Roux, S. Ory, T. Nheu, P. Jurdic, C. Rabourdin-Combe, and A. L. Astier
CD46/CD3 Costimulation Induces Morphological Changes of Human T Cells and Activation of Vav, Rac, and Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase
J. Immunol., December 15, 2001; 167(12): 6780 - 6785.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Prlic, B. R. Blazar, A. Khoruts, T. Zell, and S. C. Jameson
Homeostatic Expansion Occurs Independently of Costimulatory Signals
J. Immunol., November 15, 2001; 167(10): 5664 - 5668.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Martin, D. J. Metzger, S. M. Michalek, T. D. Connell, and M. W. Russell
Distinct Cytokine Regulation by Cholera Toxin and Type II Heat-Labile Toxins Involves Differential Regulation of CD40 Ligand on CD4+ T Cells
Infect. Immun., July 1, 2001; 69(7): 4486 - 4492.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. R. Hayward, M. Cosyns, M. Jones, and E. M. Ponnuraj
Marrow-Derived CD40-Positive Cells Are Required for Mice To Clear Cryptosporidium parvum Infection
Infect. Immun., March 1, 2001; 69(3): 1630 - 1634.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Howard and S. D. Miller
Autoimmune Intervention by CD154 Blockade Prevents T Cell Retention and Effector Function in the Target Organ
J. Immunol., February 1, 2001; 166(3): 1547 - 1553.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Grohmann, F. Fallarino, S. Silla, R. Bianchi, M. L. Belladonna, C. Vacca, A. Micheletti, M. C. Fioretti, and P. Puccetti
CD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells
J. Immunol., January 1, 2001; 166(1): 277 - 283.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.